Related Experiment Video
Updated: Jul 14, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Hepatocellular Carcinoma-Southeast Asia Updates
Satender Pal Singh1, Vinod Arora, Tushar Madke
1From the Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Hepatocellular carcinoma (HCC), a major global cancer, shows shifting causes from viral to nonviral, particularly in high-income regions. Understanding these trends is key for effective prevention and management strategies.
Area of Science:
- Hepatology and Oncology
- Epidemiology
- Public Health
Background:
- Hepatocellular carcinoma (HCC) is a significant global health challenge, often developing in individuals with genetic susceptibility and risk factors like liver cirrhosis.
- Epidemiological trends reveal a geographic and temporal shift in HCC etiologies, moving from predominantly viral causes in Asia and Africa to nonviral causes in high sociodemographic index regions.
- Genetic predispositions to HCC are recognized, though less frequently diagnosed outside North America and Europe.
Approach:
- This review synthesizes current epidemiologic data on hepatocellular carcinoma.
- It evaluates the evolving risk factors associated with HCC development globally.
- The review also discusses current strategies for HCC prevention, surveillance, and management.
Key Points:
- HCC incidence and causes vary significantly by region and socioeconomic status.
- Hepatitis viruses remain primary drivers of HCC in many parts of Asia and Africa.
- Nonviral causes and genetic factors are increasingly implicated, especially in developed nations.
Conclusions:
- Effective HCC prevention and management require tailored strategies that account for regional epidemiologic variations and evolving risk factors.
- Surveillance and timely intervention are crucial for improving outcomes in patients at risk for HCC.
- Further research into genetic predispositions and nonviral risk factors is essential for a comprehensive approach to combating HCC worldwide.
More Related Videos
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019